re: re 14c s'term target.why the fall then > mightybullwhat do reckon sie chances are of being cashflow positive this quarter?im long and have been for a while
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%